Blog
RSS FeedPosted by Michael Wonder on 03 Jun 2017
More health plans are eyeing deals for drugs based on patient outcomes
1 June 2017 - As the cost of prescription drugs remains vexing, a new survey finds that more health plans ...
Posted by Michael Wonder on 03 Jun 2017
Pfizer announces acceptance of regulatory submissions by U.S. FDA and EMA for Sutent (sunitinib) for adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma after surgery
31 May 2017 - Applications seek to expand approved use of Sutent based on data from the Phase 3 S-TRAC trial. ...
Posted by Michael Wonder on 02 Jun 2017
Express Scripts sues maker of overdose drug, intensifying feud
31 May 2017 - A company that manages prescription drug plans for tens of millions of Americans has sued a ...
Posted by Michael Wonder on 02 Jun 2017
Single payer healthcare is popular with Californians — unless it raises their taxes
31 May 2017 - Almost two of every three Californians in a new statewide poll said they like the idea ...
Posted by Michael Wonder on 02 Jun 2017
Roche announces FDA approval of companion diagnostic to identify ALK positive non-small-cell lung cancer patients
1 June 2017 - The Ventana ALK CDx assay identifies ALK positive non-small-cell lung cancer patients eligible for treatment with the ...
Posted by Michael Wonder on 01 Jun 2017
More new cancer drugs mean higher costs but also longer lives
1 June 2017 - Spending on cancer treatments has spiked past the $100 billion mark globally over the past five ...
Posted by Michael Wonder on 01 Jun 2017
EpiPen outrage: Drug maker Mylan may have gouged US taxpayers by $1.7 billion
1 June 2017 - American taxpayers may have overpaid for Mylan's EpiPen shot by as much as $US1.27 billion ($1.71 billion) ...
Posted by Michael Wonder on 01 Jun 2017
Novo Nordisk receives US FDA approval of Rebinyn (nonacog beta pegol; N9-GP)
31 May 2017 - Novo Nordisk today announced that the US FDA has approved the biologics license application for Rebinyn ...
Posted by Michael Wonder on 01 Jun 2017
Nicox receives FDA approval of Zerviate (cetirizine ophthalmic solution) 0.24%
31 May 2017 - U.S. patent protection until at least 2030. ...
Posted by Michael Wonder on 01 Jun 2017
Jazz Pharmaceuticals announces FDA acceptance of NDA for Vyxeos (CPX-351), an investigational treatment for acute myeloid leukaemia, with priority review status
31 May 2017 - Jazz Pharmaceuticals today announced that the U.S. FDA has accepted for filing with priority review its recently ...
Posted by Michael Wonder on 31 May 2017
ProQR receives fast track designation from the FDA for QR-110 for Leber’s congenital amaurosis type 10
31 May 2017 - QR-110 is currently in clinical development with the planned Phase 1/2 open-label trial (PQ-110-001) that will assess ...
Posted by Michael Wonder on 31 May 2017
FDA grants breakthrough therapy designation for Alnylam's givosiran for the prophylaxis of attacks in patients with acute hepatic porphyria
31 May 2017 - Company plans to initiate Phase 3 clinical program in late 2017. ...
Posted by Michael Wonder on 31 May 2017
Drug makers brace for Trump's proposals to tackle U.S. prices
31 May 2017 - Novartis, Allergan CEOs foresee action in coming months. ...
Posted by Michael Wonder on 31 May 2017
How a Supreme Court ruling on printer cartridges could have a big impact on drug prices
30 May 2017 - A Supreme Court ruling on international printer cartridge sales could have major implications for, of all ...
Posted by Michael Wonder on 31 May 2017
Indivior submits new drug application to U.S. FDA for RBP-6000 buprenorphine monthly depot
30 May 2017 - A potential novel long-acting, sustained release product candidate for treatment of opioid use disorder. ...